Fluidigm to Present at Upcoming Health Care Investor Conferences
14 May 2020 - 6:02AM
Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology
tools provider with a vision to improve life through comprehensive
health insight, announced today that Chris Linthwaite, President
and Chief Executive Officer, and Vikram Jog, Chief Financial
Officer, will present updates regarding Fluidigm’s business
strategy and financial performance at the following upcoming
investor conferences:
- UBS Virtual Global Healthcare Conference, on Tuesday, May 19,
2020, at 4:40 p.m. ET.
- Jefferies Virtual Healthcare Conference, on Wednesday, June 3,
2020, at 3:00 p.m. ET.
A live webcast of each presentation and subsequent replay will
be available in the Events & Presentations section of the
Company’s investor website. Each webcast will be archived for 30
days following the live presentation.
About Fluidigm Fluidigm (Nasdaq:FLDM) is an
industry-leading biotechnology tools provider with a vision to
improve life through comprehensive health insight. We focus on the
most pressing needs in translational and clinical research,
including cancer, immunology, and immunotherapy. Using proprietary
CyTOF® and microfluidics technologies, we develop, manufacture, and
market multi-omic solutions to drive meaningful insights in health
and disease, identify biomarkers to inform decisions, and
accelerate the development of more effective therapies. Our
customers are leading academic, government, pharmaceutical,
biotechnology, and plant and animal research laboratories
worldwide. Together with them, we strive to increase the quality of
life for all. For more information, visit fluidigm.com.
Fluidigm, the Fluidigm logo and CyTOF are trademarks and/or
registered trademarks of Fluidigm Corporation in the United States
and/or other countries. All other trademarks are the sole property
of their respective owners. Fluidigm products are provided for
Research Use Only. Not for use in diagnostic procedures.
Available Information We use our website
(fluidigm.com), investor site (investors.fluidigm.com), corporate
Twitter account (@fluidigm), Facebook page (facebook.com/Fluidigm),
and LinkedIn page (linkedin.com/company/fluidigm-corporation) as
channels of distribution of information about our products, our
planned financial and other announcements, our attendance at
upcoming investor and industry conferences, and other matters. Such
information may be deemed material information, and we may use
these channels to comply with our disclosure obligations under
Regulation FD. Therefore, investors should monitor our website and
our social media accounts in addition to following our press
releases, SEC filings, public conference calls, and
webcasts.
Contact:
Fluidigm Corporation
Agnes LeeVice President, Investor Relations650 416
7423agnes.lee@fluidigm.com
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From Apr 2024 to May 2024
Fluidigm (NASDAQ:FLDM)
Historical Stock Chart
From May 2023 to May 2024